Proposed Changes to Review Criteria for NIH Grant Applications

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

NIH is considering new review criteria and is currently seeking public input via a request for information (RFI), which is open through March 10, 2023. We include more details below, but it is worth noting that there is generally favorable support for these criteria and our guess is that they will be implemented perhaps within the year. If implemented, NIH grant writers should consider including the new subheaders in their research strategy to reflect the simplified scoring criteria.

Currently, applications for research project grants (the “R” grants) are evaluated based on Significance, Investigators, Innovation, Approach, and Environment. Under the new scoring criteria, grants will be evaluated as follows:

  • Factor 1: Importance of the Research (Significance, Innovation), numerical score (1-9)
  • Factor 2: Rigor and Feasibility (Approach), numerical score (1-9)
  • Factor 3: Expertise and Resources (Investigator, Environment), assessed and considered in the Overall Impact Score, but not individually scored

NIH provided the following diagram to help map the transition from the current review criteria to the proposed one:

The proposed changes will allow peer reviewers to focus on scientific merit by evaluating 1) the scientific impact, research rigor, and feasibility of the proposed research without the distraction of administrative questions and 2) whether or not appropriate expertise and resources are available to conduct the research, thus mitigating the undue influence of the reputation of the institution or investigator.

More information regarding the history behind this proposed change is available here. The message board at the bottom of that page will also let you see what others’ perspectives are regarding this initiative.

Dr. Meg Bouvier

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
Related posts

You May Also Be Interested In

Bouvier Grant Group logo white
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH October 2023 Newsletter cover